Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-003039

Options or other derivatives

  • EVP, CHIEF LEGAL OFFICER, SEC acquired 152,478 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC 2024-02-06 Grant or award · Stock Option (Right to Buy) +126,589 126,589 D
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC 2024-02-06 Grant or award · Restricted Stock Units +25,889 25,889 D
Loading xslF345X05/form4-02082024_100202.xml…